Increasingly Positive Cancer Outcomes Puts Cardiac Side Effects Center Stage
The five-year relative survival for all cancer sites has been steadily improving since the 1980s. Because cancer is becoming [...]
Blog Post: Visikol Supports Neurodegenerative Disease Research
Mike Johnson2020-07-07T13:24:35-05:00Diseases characterized by the progressive deterioration of the structure and function of the central nervous system or the peripheral [...]
Incorporate qPCR into your Cell Based Assay
Mike Johnson2020-06-25T14:21:44-05:00At Visikol, we offer our Clients an array of 2D and 3D cell culture assays with a wide range [...]
Blog Post: Eye Biology
Age-related macular degeneration (AMD), is a medical condition that affects the center of the visual field and causes blurriness [...]
The Importance of Cell Subtypes in NASH Models
Since its inception, Visikol has worked diligently to develop assays, in both 2D and 3D modalities, to explore complex [...]
Blog Post: Immune Cell Infiltration Assay
The search for immunotherapies that are effective in their treatment of cancers has been ongoing with varying degree of [...]
Head of Services Erin Edwards Chats with ThermoFisher about HCS
In this article, Visikol Head of Services Erin Edwards chats with Cameron Smurthwaite from ThermoFisher about how Visikol is [...]
Visikol Launches Imaging Mass Cytometry Services
Hampton, NJ --- As a leader in advanced tissue imaging and digital pathology services, Visikol is excited to announce [...]
An update on Visikol and our operations during the Coronavirus pandemic
We hope that all of our clients, customers and collaborators are doing well during these difficult times and that [...]
Visikol Now Offering Precision Cut Tissue Slice Models for Use in Services
Many advanced in vitro cell culture models such as 3D co-culture systems or organ-on-a-chip have been developed in order [...]